Syndax Pharmaceuticals Inc.;Merck Patent GmbH;Pfizer Inc.
发明人:
ORDENTLICH, Peter,MEYERS, Michel
申请号：
EP16882544
公开号：
EP3397262A4
申请日:
2016.12.28
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Described herein are methods for the treatment of heavily pre-treated recurrent ovarian cancer. In particular, methods are provided for the treatment of heavily pre-treated recurrent ovarian cancer with a combination of entinostat and an anti-PD-L1 antibody.
